Vanguard Group Inc Vericel Corp Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Vericel Corp stock. As of the latest transaction made, Vanguard Group Inc holds 3,563,471 shares of VCEL stock, worth $115 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,563,471

Previous 3,493,510 2.0%

Holding current value

$115 Million

Previous $156 Million 2.73%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$37.92 - $45.7 $2.65 Million - $3.2 Million	69,961 Added 2.0%	3,563,471 $152 Million
Q1 2025 May 09, 2025	BUY	$44.5 - $61.8 $355,021 - $493,040	7,978 Added 0.23%	3,493,510 $156 Million
Q4 2024 Feb 11, 2025	BUY	$40.05 - $59.11 $65,521 - $96,703	1,636 Added 0.05%	3,485,532 $191 Million
Q3 2024 Nov 13, 2024	BUY	$42.25 - $53.56 $1.66 Million - $2.1 Million	39,214 Added 1.14%	3,483,896 $147 Million
Q2 2024 Aug 13, 2024	BUY	$41.71 - $52.9 $1.3 Million - $1.65 Million	31,240 Added 0.92%	3,444,682 $158 Million
Q1 2024 May 10, 2024	BUY	$32.52 - $52.33 $1.28 Million - $2.06 Million	39,349 Added 1.17%	3,413,442 $178 Million
Q4 2023 Feb 14, 2024	BUY	$30.85 - $37.09 $1.5 Million - $1.8 Million	48,514 Added 1.46%	3,374,093 $120 Million
Q3 2023 Nov 14, 2023	SELL	$31.69 - $39.25 $118,425 - $146,677	-3,737 Reduced 0.11%	3,325,579 $111 Million
Q2 2023 Aug 14, 2023	SELL	$29.0 - $38.37 $477,804 - $632,184	-16,476 Reduced 0.49%	3,329,316 $125 Million
Q1 2023 May 15, 2023	BUY	$23.85 - $31.34 $903,056 - $1.19 Million	37,864 Added 1.14%	3,345,792 $98.1 Million
Q4 2022 Feb 10, 2023	BUY	$17.65 - $27.37 $1.3 Million - $2.02 Million	73,833 Added 2.28%	3,307,928 $87.1 Million
Q3 2022 Nov 14, 2022	BUY	$22.62 - $32.54 $2.01 Million - $2.89 Million	88,923 Added 2.83%	3,234,095 $75 Million
Q2 2022 Aug 12, 2022	BUY	$22.88 - $39.45 $3.22 Million - $5.55 Million	140,645 Added 4.68%	3,145,172 $79.2 Million
Q1 2022 May 13, 2022	SELL	$31.69 - $43.29 $1.41 Million - $1.93 Million	-44,536 Reduced 1.46%	3,004,527 $115 Million
Q4 2021 Feb 14, 2022	BUY	$35.2 - $52.6 $207,116 - $309,498	5,884 Added 0.19%	3,049,063 $120 Million
Q3 2021 Nov 12, 2021	BUY	$46.35 - $59.75 $583,361 - $752,013	12,586 Added 0.42%	3,043,179 $149 Million
Q2 2021 Aug 13, 2021	BUY	$47.2 - $67.81 $143 Million - $206 Million	3,030,593 New	3,030,593 $159 Million

Others Institutions Holding VCEL

# of Institutions

296

Shares Held

54.3M

Call Options Held

35.6K

Put Options Held

7.7K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $1.52B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Vericel Corp Transaction History